Amgen (AMGN) data supports long-term growth potential says analyst

Go back to Amgen (AMGN) data supports long-term growth potential says analyst

AMGEN PRESENTS NEW REPATHA® (EVOLOCUMAB) DATA AT AHA 2022

November 7, 2022 4:16 PM EST

Very low LDL-C Levels... More